Opinion|Videos|May 28, 2024
Utilization of APOE4 Genotype in Management of Alzheimer’s Disease
Medical experts discuss the application of ApoE gene polymorphism and copy number data in managing Alzheimer's disease, highlighting its relevance for individuals with a family history of AD, and symptomatic patients.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- How are you utilizing ApoE gene polymorphism and copy numbers data to manage AD?
Advertisement
Related to this article
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.
PridCor Therapeutics is moving its phase 2 SHIELD trial of a combination antiviral regimen toward enrollment, building on case series data showing durable symptom improvement in long COVID.
Here's some of what is coming soon to NeurologyLive® this week.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
12-Month Gluten-Free Diet Linked to Cognitive, Quality-of-Life Improvements in Parkinson Disease
2
LRRK2 Inhibitor BIIB122 Fails to Slow Early-Stage Parkinson Disease
3
GLP-1/GIP Agonist KP405 Shows Biomarker Signal in Parkinson Disease
4
Phase 1 Data Link ARV-102 LRRK2 Degradation to Oculomotor and CSF Biomarker Changes in Parkinson Disease
5